AT277628T
Cxcr4 agonist treatment of hematopoietic cells
Abstract
This record has no abstract on file.
Term
Term ended
Expired 12 April 2021, 5.5 years ago.
- Priority
- Filed
- Granted
- Expired
- Today
107 members in 10 offices
Priority claims4
| Document | Office | Kind | Date |
|---|---|---|---|
| 2305036 | Canada | A | |
| 23242500 | United States of America | P | |
| 2335109 | Canada | A | |
| 0100540 | Canada | W |
Members107
| Document | Office | Kind | |
|---|---|---|---|
| CA2226391A1 | Canada | A1 | |
| CA2322764A1 | Canada | A1 | |
| WO9947158A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2821699A | Australia | A | |
| WO9947158A3 | World Intellectual Property Organization (WIPO) | A3 | |
| CA2245224A1 | Canada | A1 | |
| WO0009152A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU5274499A | Australia | A | |
| EP1061944A2 | European Patent Office (EPO) | A2 | |
| CA2305036A1 | Canada | A1 | |
| CA2335109A1 | Canada | A1 | |
| CA2405907A1 | Canada | A1 | |
| WO0176615A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU5208101A | Australia | A | |
| CA2305787A1 | Canada | A1 | |
| CA2408319A1 | Canada | A1 | |
| WO0185196A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU5811001A | Australia | A | |
| WO0176615A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO0185196A3 | World Intellectual Property Organization (WIPO) | A3 | |
| JP2002506830A | Japan | A | |
| US2002156034A1 | United States of America | A1 | |
| US2002165123A1 | United States of America | A1 | |
| EP1276493A2 | European Patent Office (EPO) | A2 | |
| EP1286684A2 | European Patent Office (EPO) | A2 | |
| AU762472B2 | Australia | B2 | |
| BR0110049A | Brazil | A | |
| US2003148940A1 | United States of America | A1 | |
| JP2003530355A | Japan | A | |
| JP2003532683A | Japan | A | |
| EP1061944B1 | European Patent Office (EPO) | B1 | |
| AT258444T | Austria | T | |
| ATE258444T1 | Austria | T1 | |
| DE69914463D1 | Germany | D1 | |
| CA2498723A1 | Canada | A1 | |
| WO2004024088A2 | World Intellectual Property Organization (WIPO) | A2 | |
| EP1286684B1 | European Patent Office (EPO) | B1 | |
| AU2003279715A1 | Australia | A1 | |
| AT265219T | Austria | T | |
| ATE265219T1 | Austria | T1 | |
| DE60103052D1 | Germany | D1 | |
| EP1276493B1 | European Patent Office (EPO) | B1 | |
| US2004197303A1 | United States of America | A1 | |
| AT277628TThis record | Austria | T | |
| ATE277628T1 | Austria | T1 | |
| DE60106002D1 | Germany | D1 | |
| DE69914463T2 | Germany | T2 | |
| AU2001252081B2 | Australia | B2 | |
| WO2004024088A3 | World Intellectual Property Organization (WIPO) | A3 | |
| DE60103052T2 | Germany | T2 | |
| US2005059584A1 | United States of America | A1 | |
| US6875738B1 | United States of America | B1 | |
| AU2001252081B9 | Australia | B9 | |
| EP1536834A2 | European Patent Office (EPO) | A2 | |
| BR0314212A | Brazil | A | |
| US2005164935A1 | United States of America | A1 | |
| US6946445B1 | United States of America | B1 | |
| US2005265969A1 | United States of America | A1 | |
| JP2005539063A | Japan | A | |
| US2006014682A1 | United States of America | A1 | |
| DE60106002T2 | Germany | T2 | |
| CA2515158A1 | Canada | A1 | |
| CN1742997A | China | A | |
| AU2005205737A1 | Australia | A1 | |
| EP1642588A2 | European Patent Office (EPO) | A2 | |
| JP2006117633A | Japan | A | |
| BRPI0504758A | Brazil | A | |
| EP1642588A3 | European Patent Office (EPO) | A3 | |
| US7091310B2 | United States of America | B2 | |
| AU2001258110B2 | Australia | B2 | |
| US2006233748A1 | United States of America | A1 | |
| US2006252687A1 | United States of America | A1 | |
| AU2006252077A1 | Australia | A1 | |
| AU2006252080A1 | Australia | A1 | |
| US2007066523A1 | United States of America | A1 | |
| JP2007106768A | Japan | A | |
| US2007116669A1 | United States of America | A1 | |
| US2007160574A1 | United States of America | A1 | |
| WO2007079460A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO2007079460A3 | World Intellectual Property Organization (WIPO) | A3 | |
| EP1834961A2 | European Patent Office (EPO) | A2 | |
| US2007225216A1 | United States of America | A1 | |
| EP1536834A4 | European Patent Office (EPO) | A4 | |
| US2007275892A9 | United States of America | A9 | |
| WO2007138382A2 | World Intellectual Property Organization (WIPO) | A2 | |
| EP1882698A1 | European Patent Office (EPO) | A1 | |
| JP2008031143A | Japan | A | |
| BR0314212C1 | Brazil | C1 | |
| US7354899B2 | United States of America | B2 | |
| CA2564924A1 | Canada | A1 | |
| US7368425B2 | United States of America | B2 | |
| US7378098B2 | United States of America | B2 | |
| EP1834961A3 | European Patent Office (EPO) | A3 | |
| CN101200502A | China | A | |
| US7423011B2 | United States of America | B2 | |
| US7435718B2 | United States of America | B2 | |
| WO2007138382A3 | World Intellectual Property Organization (WIPO) | A3 | |
| US2008318855A1 | United States of America | A1 | |
| US2009098091A1 | United States of America | A1 | |
| JP2009143942A | Japan | A |
Showing 100 of 107
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Ceased as to paragraph 5 lit. 3 law introducing patent treatiesCeasedRER | RER |
Numbers
- Application
- 1925259
Titles2
- German
- BEHANDLUNG VON HEMATOPOIETISCHEN ZELLEN MIT CXCR4 AGONISTEN
- English
- TREATMENT OF HEMATOPOIETIC CELLS WITH CXCR4 AGONISTS
Classification
- CPC, 6
- C07K14/522
- A61K38/195
- A61P35/00
- A61P35/02
- A61P35/04
- A61P37/00
- IPC, 6
- A61K38 00
- A61K38 19
- A61K45 00
- A61P35 00
- A61P37 00
- C07K14 715